A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg (Q24805534)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

title

A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

author name string

F M Brennan

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

language of work or name

English

0 references

publication date

24 April 2001

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

published in

Arthritis Research and Therapy

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

volume

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

issue

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

page(s)

211-3; discussion 214-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

cites work

Anti-cytokine therapy in chronic destructive arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

7 April 2017

Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

7 April 2017

Interleukin-1 receptor antagonist: role in biology

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

7 April 2017

The interleukin-1 family: 10 years of discovery

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

7 April 2017

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

7 April 2017

Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearance during lethal bacteremia

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

28 September 2017

Constitutive activity of the tumor necrosis factor promoter is canceled by the 3' untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

28 September 2017

Gene therapy for arthritis: principles and clinical practice

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

28 September 2017

Anti-tumor necrosis factor-alpha therapy of rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

28 September 2017

Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

30 May 2018

Translational blockade imposed by cytokine-derived UA-rich sequences

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

30 May 2018

Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

30 May 2018

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

28 November 2018

Modulation of proinflammatory cytokine release in rheumatoid synovial membrane cell cultures. Comparison of monoclonal anti TNF-alpha antibody with the interleukin-1 receptor antagonist.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=128897

retrieved

28 November 2018

A comparative study into the mechanisms of action of anti-tumor necrosis factor alpha, anti-CD4, and combined anti-tumor necrosis factor alpha/anti-CD4 treatment in early collagen-induced arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic anti-tumor necrosis factor α therapy in rheumatoid arthritis down-regulates synovial tumor necrosis factor α synthesis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of TNF-alpha and IL-1 blockade in collagen-induced arthritis and comparison with combined anti-TNF-alpha/anti-CD4 therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytokine appearance in human endotoxemia and primate bacteremia

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of serum matrix metalloproteinase 1 and matrix metalloproteinase 3 in rheumatoid arthritis patients following anti- tumour necrosis factor-alpha (cA2) therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DBA/1 mice expressing the human TNF-alpha transgene develop a severe, erosive arthritis: characterization of the cytokine cascade and cellular composition

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/11438037

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/AR302

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

PMC publication ID

128897

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

PubMed publication ID

11438037

1 reference

stated in

Europe PubMed Central

PubMed publication ID

11438037

retrieved

5 July 2017

ResearchGate publication ID

11903165

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q24805534&oldid=2175294803"